Treatment of nasopharyngeal tumors: Literature review;Les traitements des cancers du nasopharynx: Revue de la littérature

Cancer/Radiotherapie

Volumn 6, Issue 2, 2002, Pages 59-84

  Noel G ^a,b   Dessard Diana, B ^a   Vignot, S ^a   Mazeron, J J ^a,b  

^a Ctr de Protontherapie d'Orsay   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Chemotherapy; Nasopharyngeal cancer; Radiotherapy; Relapse

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; METHOTREXATE; MITOMYCIN; UFT; VINCRISTINE;

ADJUVANT CHEMOTHERAPY; BRACHYTHERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER STAGING; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; DOSIMETRY; HUMAN; NASOPHARYNX TUMOR; NEUROLOGICAL COMPLICATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RELAPSE; REVIEW; STEREOTAXIC SURGERY; SURVIVAL RATE;

EID: 0036237018     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1278-3218(02)00150-6     Document Type: Short Survey

References (186)

1. Distant metastases of nasopharyngeal carcinoma: A study of 256 males patients
2. Fractionated stereotactic radiation therapy for extracranial head and neck tumors
3. Chemotherapeutic management of head and neck cancer
4. Head and neck cancer: Chemotherapy concepts
5. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized intergroup study 0099
6. Undifferentiated nasopharyngeal cancer (UCNT): Current diagnostic and therapeutic aspects
7. Concomitant boost radiotherapy schedules in the treatment of carcinoma of the oropharynx and nasopharynx
8. Nasopharyngeal carcinoma: Result of treatment with cis-diamminedichloro-platinum II, 5-fluorouracil and radiation therapy
9. Paclitaxel in metastatic nasopharyngeal cancer
10. Alternating chemoradiotherapy with cisplatin and 5-fluorouracil plus bléomycine by continuous infusion for locally advanced undifferentiated carcinoma nasopharyngeal type
11. High complete response in advanced nasopharyngeal carcinoma with bleomycin, epirubicin, and cisplatin before radiotherapy
12. Traitement du cancer du cavum ayant localement récidivé par une nouvelle radiothérapie externe: À propos de neuf cas
13. Analysis of failures after definitive irradiation for epidermoid carcinoma of the nasopharynx
14. Four-day continuous infusion of cisplatin and 5-fluorouracil in head and neck cancer
15. Chemotherapy of metastatic and/or recurrent undifferentiated nasopharyngeal carcinoma with cisplatin, bleomycin and fluorouracil
16. Proton therapy for carcinoma of the nasopharynx: A study in comparative treatment planning
17. Linac radiosurgery for locally recurrent nasopharyngeal carcinoma: Rationale and technique
18. Carcinoma of the nasopharynx: Results of radiation treatment and some prognostic factors
19. A prospective randomised study of chemotherapy adjunctive to definitive radiotherapy in advanced nasopharyngeal carcinoma
20. The role of chemotherapy in the management of nasopharyngeal carcinoma
21. The role of brachytherapy in early-stage nasopharyngeal carcinoma
22. Locally recurrent nasopharyngeal carcinoma
23. Radiation therapy for nasopharyngeal carcinoma: Retrospective review of 105 patients based on a survey of Kansai Cancer Therapist Group
24. Prospective hormone study of hypothalamic-pituitary function in patients with nasopharyngeal carcinoma after high dose irradiation
25. Long-term observation after radiotherapy for nasopharyngeal carcinoma (NPC)
26. Concomitant radiotherapy and chemotherapy for early-stage nasopharyngeal carcinoma
27. A phase II study of outpatient chemotherapy with cisplatin, 5-fluorouracil, and leucovorin in nasopharyngeal carcinoma
28. Reduced hypothalamic blood flow after radiation treatment of nasopharyngeal cancer. SPECT studies in 34 patients
29. Concomitant infusion cisplatin and hyperfractionated radiotherapy for locally advanced nasopharyngeal and paranasal sinus tumors
30. Detection of recurrent nasopharyngeal carcinoma: MR imaging versus CT
31. Chemotherapy for recurrent or metastatic carcinoma of the nasopharynx. A review of the Princess Margaret Hospital experience
32. Transpalatal insertion of radioactive gold grain for the treatment of persistent and recurrent nasopharyngeal carcinoma
33. Irradiation of nasopharyngeal carcinoma: Correlations with treatment factors and stage
34. Locally recurrent nasopharyngeal carcinoma: Treatment results for patients with tomography assessment
35. Preliminary report of the Asian Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with loco regionally advanced nasopharyngeal carcinoma
36. Patterns of failure after induction chemotherapy and radiotherapy for locoregionally advanced nasopharyngeal carcinoma: The Queen Mary Hospital experience
37. Volumetric analysis of tumor extent in nasopharyngeal carcinoma and correlation with treatment outcome
38. Prognostic value of paranasopharyngeal extension of nasopharyngeal carcinoma. A significant factor in local control and distant metastasis
39. Nasopharyngeal carcinoma: The Dana-Farber Cancer Institute experience with 24 patients treated with induction chemotherapy and radiotherapy
40. On the epidemiology of nasopharyngeal carcinoma
41. Radiosurgery for skull base malignancies and nasopharyngeal carcinoma
42. Improved outcome secondary to concurrent chemoradiotherapy for advanced carcinoma of the nasopharynx: Preliminary corroboration of the intergroup experience
43. Pretreatment with chemotherapy in patients with advanced head and neck cancer
44. Benign and malignant growths of the nasopharynx and their treatment with radium
45. 5-Fluoro-uracil (FU), mitomycin (M), epirubicin (E), cisplatin (C) in recurrent and/or metastatic indifferentiated nasopharyngeal carcinoma (UCNT)
46. Chemotherapy for nasopharyngeal carcinoma: A ten-year experience
47. Prognostic value of EBV markers in the clinical management of nasopharyngeal carcinoma (NPC)
48. Nasopharyngeal carcinoma
49. Adjuvant chemotherapy for advanced nasopharyngeal carcinoma
50. Effectiveness of combined induction chemotherapy and radiotherapy in advanced nasopharyngeal carcinoma
51. Multicenter phase II trial of mitoxantrone in patients with advanced nasopharyngeal carcinoma in Southeast Asia: An Asian-Oceanian Clinical Oncology Association Group study
52. Final results of the VUMCA I trial comparing neoadjuvant chemotherapy (CT) (BEC) plus radiotherapy (RT) to RT alone in undifferentiated nasopharyngeal carcinoma (UCNT)
53. Radiation therapy of nasopharyngeal carcinoma: Prognostic factors based on a 10-year follow-up of 1302 patients
54. An analysis of induction and adjuvant chemotherapy in the multidisciplinary treatment of squamous-cell carcinoma of the head and neck
55. Nasopharyngeal cancer: Epidemiology, staging, and treatment
56. Computed tomography findings of bony regeneration after radiotherapy for nasopharyngeal carcinoma with skull base destruction: Implications for local control
57. Treatment of recurrent nasopharyngeal cancer
58. Recurrent locally advanced nasopharyngeal carcinoma treated with heavy charged particle irradiation
59. Loss of local control with prolongation in radiotherapy
60. Patterns of failure in nasopharyngeal cancer treated with megavoltage irradiation
61. Combined radiotherapy and chemotherapy for nasopharyngeal carcinoma
62. Prognostic factors of carcinoma of the nasopharynx
63. Treatment of locally recurrent carcinoma of the nasopharynx
64. Combined chemotherapy with doxorubicin, bleomycin, vinblastine, dacarbazine and radiotherapy for advanced lymphoepithelioma
65. Does induction chemotherapy have a role in the management of nasopharyngeal carcinoma? Results of treatment in the era of computerized tomography
66. Endothelioma of the nasopharynx: An infiltrating tumour at the base of the skull
67. Induction chemotherapy followed by radiotherapy versus radiotherapy alone in patients with advanced nasopharyngeal carcinoma. Results of a matched cohort study
68. Carcinoma of the nasopharynx treated by radiotherapy alone: Determinants of distant metastasis and survival
69. Chemotherapeutic treatment of recurrent and/or metastatic nasopharyngeal carcinoma: A retrospective analysis of 44 cases
70. Potential gains using high-energy protons for therapy of malignant tumours
71. MRI differentiation of recurrent nasopharyngeal carcinoma from postradiation fibrosis
72. Adjuvant chemotherapy for advanced head and neck squamous carcinoma
73. Techniques of interstitial and intracavitary radiation
74. Clinical staging of NPC
75. Nasopharynx
76. Neoadjuvant chemotherapy and radiation therapy compared with radiation therapy alone in advanced nasopharyngeal carcinoma
77. Carcinoma of the nasopharynx. Eighteen years experience with megavoltage radiation therapy
78. Salvage surgery for recurrent nasopharyngeal carcinoma
79. The survival of patients with nasopharyngeal carcinomas
80. Effect of cranial irradiation on hypothalamus-pituitary function: Follow-up study one year after radiotherapy
81. The effects of set up uncertainties on the treatment of nasopharynx cancer
82. Treatment planning and delivery of intensity-modulated radiation therapy for primary nasopharynx cancer
83. Results and prognostic factors in the retreatement of locally recurrent nasopharyngeal carcinoma
84. Preliminary results of a randomised trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy vs. radiotherapy alone in stage IV (≥ N2, MO) undifferentiated nasopharyngeal carcinoma: A positive effect on progression-free survival
85. Prognostic factors for local control in nasopharyngeal cancer (NPC): Analysis by multivariate proportional hazard models
86. Chemotherapy as a substitute for surgery in the treatment advanced resectable head and neck cancer. A report from the Northern California Oncology Group
87. Induction chemotherapy in advanced head and neck cancer. A Radiation Therapy Oncology Group Study
88. T classification and clivus margin as risk factors for determining locoregional control by radiotherapy of nasopharyngeal carcinoma
89. Nasopharyngeal carcinoma: A review of cases treated by radiotherapy and chemotherapy
90. Clinical trial of cisplatin and 5-FU infusion as initial treatment for advanced squamous cell carcinoma of the head and neck
91. Stereotactic radiosurgery for squamous cell carcinoma of the nasopharynx
92. A new method for the placement of brachytherapy probes in paranasal sinus and nasopharynx neoplasms
93. Three-dimensional photon treatment planning for carcinoma of the nasopharynx
94. Effects of cranial irradiation on hypothalamic-pituitary function-a 5-year longitudinal study in patients with nasopharyngeal carcinoma
95. Symptomatic hypothalamic-pituitary dysfunction in nasopharyngeal carcinoma patients following radiation therapy: A retrospective study
96. Effect of time, dose and fractionation on local control of nasopharyngeal carcinoma
97. T1 Nasopharyngeal carcinoma: The effect of waiting time on tumor control
98. Magnetic resonance imaging in the clinical diagnosis of late temporal lobe necrosis following radiotherapy for nasopharyngeal carcinoma
99. Re-irradiation for recurrent nasopharyngeal carcinoma: Factors affecting therapeutic ratio and ways for improvement
100. Retrospective analysis of patients with nasopharyngeal carcinoma treated during 1976-1985; Survival after local recurrence
101. Nasopharyngeal carcinoma: Local control by megavoltage irradiation
102. Clinical diagnosis of late temporal lobe necrosis following radiation therapy for nasopharyngeal carcinoma
103. Retrospective analysis of 5 037 patients with nasopharyngeal carcinoma treated during 1976-85: Overall survival and patterns of failure
104. Effects of radiation therapy on neuropsychological functioning in patients with nasopharyngeal carcinoma
105. Improved dose distributions for 3D conformal boost treatments in carcinoma of the nasopharynx
106. High dose rate intracavitary brachytherapy in the treatment of nasopharyngeal carcinoma
107. Asymptomatic temporal lobe injury after hyperfractionated radiotherapy for nasopharyngeal carcinoma. Incidence and determinants
108. Salvage radiation therapy for locally recurrent nasopharyngeal carcinoma
109. Salvage radiation therapy with locally persistent nasopharyngeal carcinoma
110. Fractionated high-dose-rate brachytherapy in primary carcinoma of the nasopharynx
111. Nasopharyngeal carcinoma: Repeat treatment with conformal proton therapy-dose-volume histogram analysis
112. Issues in the management of nasopharyngeal carcinoma
113. Trends in the clinical management of nasopharyngeal carcinoma
114. A treatment planning inter-comparison of proton and intensity modulated photon radiotherapy
115. Comparison of continuous and split-course radiotherapy for nasopharyngeal carcinoma-an analysis of 1446 cases with squamous cell carcinoma grade 3
116. Comparison of continuous and split-course radiotherapy for nasopharyngeal carcinoma
117. Long-term follow-up of IgG and IgA antibodies against viral capsid antigens of Epstein-Barr virus in nasopharyngeal carcinoma
118. Metastatic undifferentiated carcinoma of nasopharyngeal type treated with bleomycin (B), epirubicin (E), and cisplatin (C): Final report
119. Phase II study: Concurrent chemoradiotherapy in advanced nasopharyngeal carcinoma
120. Split course radiotherapy of carcinoma of the nasopharynx: Results of a national collaborative clinical trial of the Radiation Therapy Oncology Group
121. Megavoltage irradiation of epithelial tumors of the nasopharynx
122. The role of stereotactic radiosurgery in the treatment of malignant skull base tumors
123. A new staging system for nasopharyngeal carcinoma in China
124. Epstein-Barr virus-related antibody
125. Concurrent chemoradiation in patients with locally advanced nasopharyngeal carcinoma of the undifferentiated type
126. Carcinoma of the nasopharynx: Factors affecting prognosis
127. Radiothérapie conformationnelle des cancers des voies aérodigestives supérieures
128. Re-treatment of nasopharyngeal carcinoma in 53 patients
129. Analysis of 1379 patients with nasopharyngeal carcinoma treated by radiation
130. Carcinoma of the nasopharynx. An analysis of 91 cases and a comparison of differing treatment approaches
131. Improved complete response rate and survival in advanced head and neck cancer after three-course induction therapy with 120-hour 5-FU infusion and cisplatin
132. Adjuvant chemotherapy with vincristine, cyclophosphamide, and doxorubicin after radiotherapy in local-regional nasopharyngeal cancer: Results of a 4-year multicenter randomized study
133. Carcinoma of the nasopharynx treated by radiotherapy alone: Determinants of local and regional control
134. Radiation therapy and concurrent cisplatin in management of locoregionally advanced nasopharyngeal carcinomas
135. Radiotherapy for nasopharyngeal carcinoma: Shielding the pituitary may improve therapeutic ratio
136. Nasopharyngeal carcinoma: CT evaluation of patterns of tumor spread
137. Extent of nasopharyngeal carcinoma involvement inside the nasopharynx. Lack of prognostic value on local control
138. Histopathology of nasopharyngeal carcinoma. Correlations with epidemiology, survival rates and other biological characteristics
139. Efficacy of 4′-epidoxorubicin (pharmorubicin) in advanced nasopharyngeal carcinoma
140. Nasopharyngeal cancer a review of 1605 patients treated radically with cobalt 60
141. Combined treatment in carcinoma of the nasopharynx
142. High-dose réirradiation of head and neck cancer with curative intent
143. Chemotherapy with cisplatin and continuous infusion of 5-fluorouracil and bleomycin for recurrent and metastatic nasopharyngeal carcinoma in Taiwan
144. Brachytherapy for primary and recurrent nasopharyngeal carcinoma: 20 Years' experience at Long Beach Memorial
145. 5-Fluorouracil (FU), bleomycin (B), epirubicin (E), cisplatine (C) in locally advanced (LA), recurrent and/or metastatic (REC/MTS) indifferentiated carcinoma nasopharyngeal type (UCNT) preliminary activity/toxicity report
146. Concurrent chemotherapy followed by adjuvant chemotherapy in Asian patients with nasopharyngeal carcinoma: Toxicities and preliminary results
147. The effect of nodal status on determinants of initial treatment response and patterns of relapse-free survival in nasopharyngeal carcinoma
148. Sequential chemotherapy and radiation for nasopharyngeal cancer: Absence of long term benefit despite a high rate of tumor control to chemotherapy
149. Chemotherapy for nasopharyngeal cancer: The CAPABLE regimen (cyclophosphamide, doxorubicin, cisplatin, methotrexate and bleomycin)
150. Stereotactic radiosurgical boost following radiotherapy in primary nasopharyngeal carcinoma: Impact on local control
151. Enhancement of local control in locally advanced node-positive nasopharyngeal carcinoma by adjunctive chemotherapy
152. Prognosticators determining survival subsequent to distant metastasis from nasopharyngeal carcinoma
153. Early tumor response and treatment toxicity after hyperfractionated radiotherapy in nasopharyngeal carcinoma
154. The prognostic significance of parapharyngeal tumour involvement in nasopharyngeal carcinoma
155. Final report of a randomised trial on altered-fractionated radiotherapy in nasopharyngeal carcinoma prematurely terminated by significant increase in neurologic complications
156. Intracavitary brachytherapy significantly enhances local control of early T-stage nasopharyngeal carcinoma: The existence of a dose-tumour-control relationship above conventional tumoricidal dose
157. A retrospective comparison between different stage classifications for nasopharyngeal carcinoma
158. Afterloading intracavitary radiation treatment of nasopharyngeal carcinoma. Description of a technique and preliminary treatment results
159. A clinical study of 407 cases of nasopharyngeal carcinoma in Hong Kong
160. Improved results in the treatment of nasopharyngeal carcinoma using combined radiotherapy and chemotherapy
161. Salvage surgery for nasopharyngeal carcinoma
162. Synchronous radiotherapy and chemotherapy in the treatment of nasopharyngeal carcinoma
163. Proton beam penumbra: Effects of separation between patient and beam modifying devices
164. A radium applicator for treating carcinoma of the nasopharynx
165. Permanent iodine-125 (I-125) boost implants after external radiation therapy in nasopharyngeal cancer
166. Patterns of failure in carcinoma of the nasopharynx: I. Failure at the primary site
167. A simple afterloading applicator for intracavitary irradiation of carcinoma of the nasopharynx
168. Long-term survival of 1 035 cases of nasopharyngeal carcinoma
169. Accelerated hyperfractionation radiation therapy for carcinoma of the nasopharynx. Techniques and results
170. Improved local control of nasopharyngeal carcinoma after intracavitary brachytherapy boost
171. Re-irradiation of recurrent nasopharyngeal carcinoma - Treatment techniques and results
172. Maxillary swing approach for resection of tumors in and around the nasopharynx
173. Efficacy of radical neck dissection for the control of cervical metastasis after radiotherapy for nasopharyngeal carcinoma
174. Salvage surgery for recurrent primary nasopharyngeal carcinoma
175. Failure of a 3D conformal boost to improve radiotherapy for nasopharyngeal carcinoma
176. Improving radiotherapy for nasopharyngeal carcinoma: A 3D boost is not enough
177. Temporal lobe and hypothalamic-pituitary dysfunction after radiotherapy for nasopharyngeal carcinoma: A distinct clinical syndrome
178. Radiation therapy of recurrent nasopharyngeal carcinoma. Report on 219 patients
179. Management of local residual primary lesion of nasopharyngeal carcinoma (NPC): Are higher doses beneficial?
180. Prognostic factors of locoregionally recurrent nasopharyngeal carcinoma - A retrospective review of 182 cases
181. Phase II study of combination carboplatin and 5-fluorouracil in metastatic nasopharyngeal carcinoma
182. Radiation therapy of nasopharyngeal carcinoma: Prognostic factors on a 10-year follow-up of 1302 patients
183. Intracavitary radiation treatment of nasopharyngeal carcinoma by the high dose rate afterloading technique
184. Immunoglobin A against viral capsid antigen of Epstein-Barr Virus and indirect mirror examination of the nasopharynx in the detection of asymptomatic nasopharyngeal carcinoma (NPC)